Research sheds light on how economies may respond to COVID-19 restrictions
New research from the Imperial College COVID-19 Response Team sheds light on how economies might respond to different levels of COVID-19 restrictions.
Dog vaccination essential for preventing rabies spread to humans and animals
A coordinated and sustained programme of dog vaccination is essential for preventing rabies spread to humans and animals, according to new research.
First WHO catalogue of tuberculosis mutations developed with Imperial
The largest catalogue of tuberculosis (TB) mutations has been developed by the WHO in collaboration with Imperial.
Global study estimates 1.5 million children have lost a caregiver from COVID-19
An estimated 1.5 million children worldwide have lost a parent, custodial grandparent, or other relative who cared for them, due to COVID-19.
Winter viruses and COVID-19 could push NHS to breaking point, warns new report
COVID-19, influenza, and the respiratory virus Respiratory Syncytial Virus (RSV), could push the NHS to breaking point this winter, a new report says.
Vaccines given in last 20 years could prevent 50 million deaths in LMICs
Vaccinations given in low- and middle-income countries (LMICs) in the last 20 years will prevent 50 million deaths from infectious diseases.
Delta variant could cause significant third wave - latest Imperial modelling
Imperial’s latest modelling suggests the Delta variant could lead to a significant third wave of hospitalisations and deaths.
Neil Ferguson: Delta variant could cause a substantial third wave of Covid-19
Professor Neil Ferguson says there is a risk of a substantial third wave of COVID-19 infections in the UK, driven by the Delta variant.
Neil Ferguson: next stage of UK roadmap ‘in the balance’
Imperial’s Professor Neil Ferguson says the next stage of the UK’s roadmap out of lockdown is ‘in the balance’ as variant B1.617.2 becomes dominant.
COVID-19 global vaccination programme: the challenges ahead
Vaccine experts from around the world spoke about the challenges of the COVID-19 global rollout at a special webinar event.
